Cardiac repair by embryonic stem-derived cells

Research output: Chapter in Book/Report/Conference proceedingChapter

21 Citations (Scopus)

Abstract

Cell transplantation approaches offer the potential to promote regenerative growth of diseased hearts. It is well established that donor cardiomyocytes stably engraft into recipient hearts when injected directly into the myocardial wall. Moreover, the transplanted donor cardiomyocytes participate in a functional syncytium with the host myocardium. Thus, transplantation of donor cardiomyocytes resulted in at least partial restoration of lost muscle mass. It is also well established that embryonic stem (ES) cells differentiate into cells of ecto-, endo-, and mesodermal lineages when cultured under appropriate conditions in vitro. Robust cardiomyogenic differentiation was frequently observed in spontaneously differentiating ES cultures. Cellular, molecular and physiologic analyses indicated that ES-derived cells were bona fide cardiomyocytes, with in vitro characteristics typical for cells obtained from early stages of cardiac development. Thus, ES-derived cardiomyocytes constitute a viable source of donor cells for cell transplantation therapies.

Original languageEnglish
Title of host publicationHandbook of Experimental Pharmacology
Pages73-100
Number of pages28
Volume174
DOIs
StatePublished - 2006

Publication series

NameHandbook of Experimental Pharmacology
Volume174
ISSN (Print)01712004
ISSN (Electronic)18650325

Fingerprint

Embryonic Stem Cells
Cardiac Myocytes
Repair
Stem cells
Restoration
Cell Transplantation
Muscle
Giant Cells
Cell- and Tissue-Based Therapy
Heart Diseases
Myocardium
Transplantation
Muscles
Growth
In Vitro Techniques

Keywords

  • Cardiac regeneration
  • Cardiomyocytes
  • Cell transplantation
  • Embryonic stem cell
  • Heart disease

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry

Cite this

Rubart-von der Lohe, M., & Field, L. (2006). Cardiac repair by embryonic stem-derived cells. In Handbook of Experimental Pharmacology (Vol. 174, pp. 73-100). (Handbook of Experimental Pharmacology; Vol. 174). https://doi.org/10.1007/3-540-31265-X-4

Cardiac repair by embryonic stem-derived cells. / Rubart-von der Lohe, Michael; Field, Loren.

Handbook of Experimental Pharmacology. Vol. 174 2006. p. 73-100 (Handbook of Experimental Pharmacology; Vol. 174).

Research output: Chapter in Book/Report/Conference proceedingChapter

Rubart-von der Lohe, M & Field, L 2006, Cardiac repair by embryonic stem-derived cells. in Handbook of Experimental Pharmacology. vol. 174, Handbook of Experimental Pharmacology, vol. 174, pp. 73-100. https://doi.org/10.1007/3-540-31265-X-4
Rubart-von der Lohe M, Field L. Cardiac repair by embryonic stem-derived cells. In Handbook of Experimental Pharmacology. Vol. 174. 2006. p. 73-100. (Handbook of Experimental Pharmacology). https://doi.org/10.1007/3-540-31265-X-4
Rubart-von der Lohe, Michael ; Field, Loren. / Cardiac repair by embryonic stem-derived cells. Handbook of Experimental Pharmacology. Vol. 174 2006. pp. 73-100 (Handbook of Experimental Pharmacology).
@inbook{adcf85b49a6446ce8c3d5b487675c74a,
title = "Cardiac repair by embryonic stem-derived cells",
abstract = "Cell transplantation approaches offer the potential to promote regenerative growth of diseased hearts. It is well established that donor cardiomyocytes stably engraft into recipient hearts when injected directly into the myocardial wall. Moreover, the transplanted donor cardiomyocytes participate in a functional syncytium with the host myocardium. Thus, transplantation of donor cardiomyocytes resulted in at least partial restoration of lost muscle mass. It is also well established that embryonic stem (ES) cells differentiate into cells of ecto-, endo-, and mesodermal lineages when cultured under appropriate conditions in vitro. Robust cardiomyogenic differentiation was frequently observed in spontaneously differentiating ES cultures. Cellular, molecular and physiologic analyses indicated that ES-derived cells were bona fide cardiomyocytes, with in vitro characteristics typical for cells obtained from early stages of cardiac development. Thus, ES-derived cardiomyocytes constitute a viable source of donor cells for cell transplantation therapies.",
keywords = "Cardiac regeneration, Cardiomyocytes, Cell transplantation, Embryonic stem cell, Heart disease",
author = "{Rubart-von der Lohe}, Michael and Loren Field",
year = "2006",
doi = "10.1007/3-540-31265-X-4",
language = "English",
isbn = "9783540261339",
volume = "174",
series = "Handbook of Experimental Pharmacology",
pages = "73--100",
booktitle = "Handbook of Experimental Pharmacology",

}

TY - CHAP

T1 - Cardiac repair by embryonic stem-derived cells

AU - Rubart-von der Lohe, Michael

AU - Field, Loren

PY - 2006

Y1 - 2006

N2 - Cell transplantation approaches offer the potential to promote regenerative growth of diseased hearts. It is well established that donor cardiomyocytes stably engraft into recipient hearts when injected directly into the myocardial wall. Moreover, the transplanted donor cardiomyocytes participate in a functional syncytium with the host myocardium. Thus, transplantation of donor cardiomyocytes resulted in at least partial restoration of lost muscle mass. It is also well established that embryonic stem (ES) cells differentiate into cells of ecto-, endo-, and mesodermal lineages when cultured under appropriate conditions in vitro. Robust cardiomyogenic differentiation was frequently observed in spontaneously differentiating ES cultures. Cellular, molecular and physiologic analyses indicated that ES-derived cells were bona fide cardiomyocytes, with in vitro characteristics typical for cells obtained from early stages of cardiac development. Thus, ES-derived cardiomyocytes constitute a viable source of donor cells for cell transplantation therapies.

AB - Cell transplantation approaches offer the potential to promote regenerative growth of diseased hearts. It is well established that donor cardiomyocytes stably engraft into recipient hearts when injected directly into the myocardial wall. Moreover, the transplanted donor cardiomyocytes participate in a functional syncytium with the host myocardium. Thus, transplantation of donor cardiomyocytes resulted in at least partial restoration of lost muscle mass. It is also well established that embryonic stem (ES) cells differentiate into cells of ecto-, endo-, and mesodermal lineages when cultured under appropriate conditions in vitro. Robust cardiomyogenic differentiation was frequently observed in spontaneously differentiating ES cultures. Cellular, molecular and physiologic analyses indicated that ES-derived cells were bona fide cardiomyocytes, with in vitro characteristics typical for cells obtained from early stages of cardiac development. Thus, ES-derived cardiomyocytes constitute a viable source of donor cells for cell transplantation therapies.

KW - Cardiac regeneration

KW - Cardiomyocytes

KW - Cell transplantation

KW - Embryonic stem cell

KW - Heart disease

UR - http://www.scopus.com/inward/record.url?scp=33644807268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644807268&partnerID=8YFLogxK

U2 - 10.1007/3-540-31265-X-4

DO - 10.1007/3-540-31265-X-4

M3 - Chapter

SN - 9783540261339

VL - 174

T3 - Handbook of Experimental Pharmacology

SP - 73

EP - 100

BT - Handbook of Experimental Pharmacology

ER -